Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription Articles published in Int J Gynaecol Obstet Retrieve available abstracts of 62 articles: HTML format

Single Articles

April 2024
1. MIYAMOTO E, Yoshihara M, Iyoshi S, Mogi K, et al
   Factors affecting the long-term prognosis of patients in the AYA generation with epithelial ovarian cancer: A multicenter propensity score matching analysis.
   Int J Gynaecol Obstet. 2024 Apr 12. doi: 10.1002/ijgo.15479.
   PubMed     Abstract available
   
   
   January 2024
2. BRENT SE, McGee J, Vicus D, Kim R, et al
   Rates of genetic consultation in high-grade serous ovarian cancer patients in the era of PARP inhibitor therapy: A population-based study.
   Int J Gynaecol Obstet. 2024 Jan 29. doi: 10.1002/ijgo.15391.
   PubMed     Abstract available
   
   
   December 2023
3. DEMISSIE L, Birara M, Tolu LB, Sium AF, et al
   Recurrent ovarian cancer in Africa: Rate and associated factors at a gynecologic oncology treatment center in Ethiopia-A cross-sectional study.
   Int J Gynaecol Obstet. 2023 Dec 26. doi: 10.1002/ijgo.15316.
   PubMed     Abstract available
   
   
   November 2023
4. LUO L, Xu N, Liu Y, Zhong S, et al
   Prognostic factors and novel nomograms for overall survival and cancer specific survival of malignant ovarian cancer patients with bone metastasis: A SEER-based study.
   Int J Gynaecol Obstet. 2023 Nov 27. doi: 10.1002/ijgo.15261.
   PubMed     Abstract available
   
   
   
5. WANG D, Ran X, He Y, Zhu L, et al
   Nomograms for predicting overall survival and cancer-specific survival of endometrioid ovarian carcinoma: A retrospective cohort study from the SEER database.
   Int J Gynaecol Obstet. 2023 Nov 27. doi: 10.1002/ijgo.15263.
   PubMed     Abstract available
   
   
   
6. GAO C, Han Y, Fan X, Dong H, et al
   A case of unilateral sclerosing stromal tumor of the ovary in a postmenopausal female.
   Int J Gynaecol Obstet. 2023 Nov 12. doi: 10.1002/ijgo.15221.
   PubMed    
   
   
   
7. MA X, Xu L, Ma F, Zhang J, et al
   Whole-tumor apparent diffusion coefficient histogram analysis for preoperative risk stratification in endometrial endometrioid adenocarcinoma.
   Int J Gynaecol Obstet. 2023 Nov 4. doi: 10.1002/ijgo.15226.
   PubMed     Abstract available
   
   
   
8. RATHAT G, Blay L, Bakenga J, Roggen N, et al
   Scarless preventive surgery.
   Int J Gynaecol Obstet. 2023;163:701-702.
   PubMed    
   
   
   September 2023
9. EL HAYEK P, Chlala W, Younes K, Ghaname W, et al
   Severe hemoperitoneum from spontaneous rupture of uterine tumor resembling ovarian sex-cord tumor: A very rare case.
   Int J Gynaecol Obstet. 2023 Sep 25. doi: 10.1002/ijgo.15151.
   PubMed    
   
   
   
10. AYHAN A, Tunc M, Akilli H, Haberal N, et al
    Fertility-sparing approach to malignant ovarian germ cell tumors - Oncologic and obstetric outocome: A retrospective study.
    Int J Gynaecol Obstet. 2023 Sep 22. doi: 10.1002/ijgo.15141.
    PubMed     Abstract available
    
    
    
11. ANDERSON D, Garcia K, Fang W, Duenas-Garcia O, et al
    Feasibility of opportunistic salpingectomy at the time of a vNOTES hysterectomy: A retrospective cohort.
    Int J Gynaecol Obstet. 2023 Sep 3. doi: 10.1002/ijgo.15085.
    PubMed    
    
    
    July 2023
12. BORELLA F, Bertero L, Valabrega G, Fucina S, et al
    Searching for prognostic markers for Stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Int J Gynaecol Obstet. 2023 Jul 27. doi: 10.1002/ijgo.15014.
    PubMed     Abstract available
    
    
    
13. LAVECCHIA M, Dubey A, Jimenez W, Reade CJ, et al
    Intraoperative predictors of appendiceal abnormalities in patients with mucinous ovarian neoplasms.
    Int J Gynaecol Obstet. 2023 Jul 24. doi: 10.1002/ijgo.15008.
    PubMed     Abstract available
    
    
    June 2023
14. MANDATO VD, Torricelli F, Mastrofilippo V, Pellegri C, et al
    Impact of 2 years of COVID-19 pandemic on ovarian cancer treatment in IRCCS-AUSL of Reggio Emilia.
    Int J Gynaecol Obstet. 2023 Jun 26. doi: 10.1002/ijgo.14937.
    PubMed     Abstract available
    
    
    
15. LOPEZ-GONZALEZ E, Rodriguez-Jimenez A, Gomez-Salgado J, Daza-Manzano C, et al
    Role of tumor volume in endometrial cancer: An imaging analysis and prognosis significance.
    Int J Gynaecol Obstet. 2023 Jun 23. doi: 10.1002/ijgo.14954.
    PubMed     Abstract available
    
    
    
16. BEREK JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, et al
    FIGO staging of endometrial cancer: 2023.
    Int J Gynaecol Obstet. 2023 Jun 20. doi: 10.1002/ijgo.14923.
    PubMed     Abstract available
    
    
    May 2023
17. EL-TAWAB SS, Kehoe S
    Synchronous ovarian and Bartholin gland carcinoma: Case report and review of literature.
    Int J Gynaecol Obstet. 2023 May 23. doi: 10.1002/ijgo.14880.
    PubMed     Abstract available
    
    
    
18. VAN STEIN RM, Sikorska K, van der Aa MA, Sonke GS, et al
    Evaluation of external validity of the OVHIPEC-1 trial in a real-world population.
    Int J Gynaecol Obstet. 2023;161:640-648.
    PubMed     Abstract available
    
    
    April 2023
19. FEGHALY I, Kourie H, Moubarak M, Chouery E, et al
    Genetic profile of borderline ovarian tumors in the Lebanese population by whole-exome sequencing.
    Int J Gynaecol Obstet. 2023 Apr 25. doi: 10.1002/ijgo.14805.
    PubMed     Abstract available
    
    
    February 2023
20. AYHAN A, Tunc M, Atasoy Karakas L, Tekelioglu T, et al
    Oncologic and obstetric outcomes of early-stage epithelial ovarian cancer patients who underwent fertility-sparing surgery (a retrospective study).
    Int J Gynaecol Obstet. 2023 Feb 24. doi: 10.1002/ijgo.14732.
    PubMed     Abstract available
    
    
    
21. FRITSCHE HA, Bullock RG
    A Reflex Testing Protocol Using Two Multivariate Index Assays Improves the Risk Assessment for Ovarian Cancer in Patients with an Adnexal Mass.
    Int J Gynaecol Obstet. 2023 Feb 23. doi: 10.1002/ijgo.14733.
    PubMed     Abstract available
    
    
    
22. YUE X, Yue Z, Wang Y, Dong Z, et al
    Value of the Copenhagen index in the diagnosis of malignant adnexal tumors: A meta-analysis.
    Int J Gynaecol Obstet. 2023;160:506-515.
    PubMed     Abstract available
    
    
    January 2023
23. XU T, Zhang L, Jiang Y, Wan Y, et al
    Clinical characteristics and serum CA19-9 combined with HE4 are valuable in diagnosing endometriosis-associated ovarian cancer.
    Int J Gynaecol Obstet. 2023 Jan 27. doi: 10.1002/ijgo.14695.
    PubMed     Abstract available
    
    
    
24. PEEYANANJARASSRI K, Nanthamongkolkul K, Jiamset I, Chusook W, et al
    Impact of appendectomy of a grossly normal appendix on the survival outcomes of mucinous ovarian carcinomas in a tertiary hospital.
    Int J Gynaecol Obstet. 2023 Jan 23. doi: 10.1002/ijgo.14689.
    PubMed     Abstract available
    
    
    
25. PARK CH, Kim SM, Kim SE, Lee DY, et al
    Five-year recurrence pattern of mature cystic teratoma according to operation type in young women.
    Int J Gynaecol Obstet. 2023;160:249-255.
    PubMed     Abstract available
    
    
    December 2022
26. LI Q, Zhang X
    Prediction of high-risk factors for ovarian metastasis in patients with endometrial cancer: A large-sample retrospective case-control study.
    Int J Gynaecol Obstet. 2022 Dec 1. doi: 10.1002/ijgo.14606.
    PubMed     Abstract available
    
    
    October 2022
27. SEABRA J, Silva A, Santos I, Almeida J, et al
    Retroperitoneal recurrence of an ovarian juvenile granulosa cell tumor: A diagnostic challenge.
    Int J Gynaecol Obstet. 2022 Oct 8. doi: 10.1002/ijgo.14496.
    PubMed    
    
    
    September 2022
28. YU H, Liang J, Liang H, Feng D, et al
    Laparoscopically assisted ovarian cystectomy with totally enclosed protective device for tumor isolation.
    Int J Gynaecol Obstet. 2022 Sep 17. doi: 10.1002/ijgo.14468.
    PubMed     Abstract available
    
    
    August 2022
29. MI D, Zhang Y, Chen S
    Serum HE4 is associated with clinical prognostic factors and survival outcome in female patients with primary peritoneal carcinoma.
    Int J Gynaecol Obstet. 2022;158:352-358.
    PubMed     Abstract available
    
    
    June 2022
30. CHENG CW, ElSahwi K, Borowsky ME, Aikman N, et al
    Sex Cord Stromal Tumor Presenting with Hair Loss in Postmenopausal Women.
    Int J Gynaecol Obstet. 2022 Jun 2. doi: 10.1002/ijgo.14293.
    PubMed    
    
    
    
31. GUNDOGDU F, Orhan N, Ozgul N, Usubutun A, et al
    Recurrent mucinous neoplasm arising in cesarean scar: A case report and review of literature.
    Int J Gynaecol Obstet. 2022;157:564-567.
    PubMed     Abstract available
    
    
    May 2022
32. SAHIN EA, Toprak S, Sayal HB, Ekinci T, et al
    Analysis of prognostic factors in grade 3 endometrioid type endometrial carcinoma.
    Int J Gynaecol Obstet. 2022 May 22. doi: 10.1002/ijgo.14277.
    PubMed     Abstract available
    
    
    
33. PERRI T, Levin G, Naor-Revel S, Eliassi-Revivo P, et al
    Risk-reducing salpingo-oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2-mutation carriers-an Israeli matched-pair study.
    Int J Gynaecol Obstet. 2022;157:431-436.
    PubMed     Abstract available
    
    
    March 2022
34. AKGOR U, Ayhan A, Shushkevich A, Ozdal B, et al
    OPEC Study- An International Multicenter Study of Ovarian Preservation in Endometrial Cancers.
    Int J Gynaecol Obstet. 2022 Mar 24. doi: 10.1002/ijgo.14190.
    PubMed     Abstract available
    
    
    February 2022
35. WANG L, Zhou C, Jiang J, Zhang Z, et al
    Clinicopathologic features of pregnancy luteoma.
    Int J Gynaecol Obstet. 2022 Feb 25. doi: 10.1002/ijgo.14161.
    PubMed     Abstract available
    
    
    January 2022
36. BARAKE C, Atwani R, Jaafar N, Tamim H, et al
    Appropriateness of hysterectomies at the time of surgical removal of presumed benign adnexal masses.
    Int J Gynaecol Obstet. 2022 Jan 22. doi: 10.1002/ijgo.14110.
    PubMed     Abstract available
    
    
    November 2021
37. TRAVAGLINO A, Raffone A, Gencarelli A, Micheli M, et al
    Dusp6 immunohistochemistry is associated with the response of atypical endometrial hyperplasia and early endometrial cancer to conservative treatment.
    Int J Gynaecol Obstet. 2021 Nov 27. doi: 10.1002/ijgo.14050.
    PubMed     Abstract available
    
    
    October 2021
38. MCCLUGGAGE WG
    Progress in the pathological arena of gynecological cancers.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:107-114.
    PubMed     Abstract available
    
    
    
39. WICHMANN IA, Cuello MA
    Obesity and gynecological cancers: A toxic relationship.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:123-134.
    PubMed     Abstract available
    
    
    
40. BEREK JS, Renz M, Kehoe S, Kumar L, et al
    Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:61-85.
    PubMed     Abstract available
    
    
    September 2021
41. LO HW, Weng SF, Chen HS, Tsai EM, et al
    Pelvic inflammatory disease is associated with ovarian cancer development in women with endometriosis: A cohort study in Taiwan.
    Int J Gynaecol Obstet. 2021 Sep 18. doi: 10.1002/ijgo.13935.
    PubMed     Abstract available
    
    
    
42. TRAVAGLINO A, Raffone A, Raimondo D, Arciuolo D, et al
    Prognostic value of the TCGA molecular classification in uterine carcinosarcoma.
    Int J Gynaecol Obstet. 2021 Sep 18. doi: 10.1002/ijgo.13937.
    PubMed     Abstract available
    
    
    
43. XU A, Nie F, Liu T, Dong T, et al
    Adnexal masses: Diagnostic performance of contrast-enhanced ultrasound (CEUS) of the simple rules from the International Ovarian Tumor Analysis group.
    Int J Gynaecol Obstet. 2021 Sep 12. doi: 10.1002/ijgo.13926.
    PubMed     Abstract available
    
    
    July 2021
44. IKEDA Y, Yoshihara M, Yoshikawa N, Tamauchi S, et al
    Is cystectomy an option as conservative surgery for young patients with borderline ovarian tumor? A multi-institutional retrospective study.
    Int J Gynaecol Obstet. 2021 Jul 29. doi: 10.1002/ijgo.13844.
    PubMed     Abstract available
    
    
    
45. MORRIS JM, Tillmanns TD, Brezina PR
    Intergenerational gestational surrogacy in a patient with ovarian dysgerminocarcinoma.
    Int J Gynaecol Obstet. 2021 Jul 13. doi: 10.1002/ijgo.13824.
    PubMed     Abstract available
    
    
    
46. KIM SR, Maganti M, Bernardini MQ, Laframboise S, et al
    Efficacy and toxicity of intraperitoneal chemotherapy as compared to intravenous chemotherapy in the treatment of patients with advanced ovarian cancer.
    Int J Gynaecol Obstet. 2021 Jul 2. doi: 10.1002/ijgo.13813.
    PubMed     Abstract available
    
    
    May 2021
47. PITARCH-MARTINEZ M, Blanco-Elena JA, Robles-Quesada MT, Alberca-Paramo A, et al
    Colonic perforation due to ovarian cancer invasion: An unusual event.
    Int J Gynaecol Obstet. 2021 May 29. doi: 10.1002/ijgo.13770.
    PubMed     Abstract available
    
    
    
48. D'ALESSANDRO G, Frigerio M, Barra F, Costantini S, et al
    Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer.
    Int J Gynaecol Obstet. 2021 May 9. doi: 10.1002/ijgo.13737.
    PubMed     Abstract available
    
    
    April 2021
49. DAHIYA A, Thomas V
    Response: Endometriosis and malignancy-The intriguing relationship.
    Int J Gynaecol Obstet. 2021 Apr 13. doi: 10.1002/ijgo.13688.
    PubMed    
    
    
    January 2021
50. CHEN Q, Wang S, Lang JH
    The impact of lymph node dissection on apparent stage I epithelial ovarian carcinoma: A population-based study.
    Int J Gynaecol Obstet. 2021 Jan 28. doi: 10.1002/ijgo.13627.
    PubMed     Abstract available
    
    
    
51. DAHIYA A, Sebastian A, Thomas A, George R, et al
    Endometriosis and malignancy: The intriguing relationship.
    Int J Gynaecol Obstet. 2021 Jan 8. doi: 10.1002/ijgo.13585.
    PubMed     Abstract available
    
    
    December 2020
52. LI S, Li H, Tian S, Wu J, et al
    Association between ovarian and breast masses among Chinese women in Chongqing based on ultrasonography screening: A cross-sectional study.
    Int J Gynaecol Obstet. 2020 Dec 23. doi: 10.1002/ijgo.13568.
    PubMed     Abstract available
    
    
    
53. KIM SR, Kotsopoulos J, Sun P, Bernardini M, et al
    The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on ten-year survival from advanced ovarian cancer.
    Int J Gynaecol Obstet. 2020 Dec 16. doi: 10.1002/ijgo.13542.
    PubMed     Abstract available
    
    
    November 2020
54. TAKEDA T, Hayashi S, Kobayashi Y, Tsuji K, et al
    Evaluation of preoperative prediction of intestinal invasion in patients with ovarian cancer.
    Int J Gynaecol Obstet. 2020 Nov 22. doi: 10.1002/ijgo.13492.
    PubMed     Abstract available
    
    
    
55. PERGIALIOTIS V, Papoutsi E, Androutsou A, Tzortzis AS, et al
    Galectins-1,-3,-7,-8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13471.
    PubMed     Abstract available
    
    
    
56. ESPIAU ROMERA A, Coronado Martin PJ, Choliz Ezquerro M, Cuesta Guardiola T, et al
    Value of preoperative HE4 as predictor of advanced disease in endometrioid endometrial cancer.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13473.
    PubMed     Abstract available
    
    
    October 2020
57. TOPRAK S, Sahin EA, Sahin H, Tohma YA, et al
    Risk factors for cervical stromal involvement in endometrioid-type endometrial cancer.
    Int J Gynaecol Obstet. 2020 Oct 28. doi: 10.1002/ijgo.13449.
    PubMed     Abstract available
    
    
    
58. AYHAN A, Akilli H
    Prognostic factors associated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer.
    Int J Gynaecol Obstet. 2020 Oct 6. doi: 10.1002/ijgo.13410.
    PubMed     Abstract available
    
    
    July 2020
59. BULDUKOGLU OC, Turker A, Usubutun A, Salman MC, et al
    Relationship of lymph node status with survival and recurrence among women with endometrial cancer.
    Int J Gynaecol Obstet. 2020 Jul 17. doi: 10.1002/ijgo.13309.
    PubMed     Abstract available
    
    
    June 2020
60. RODRIGUEZ J, Fletcher A, Heredia F, Fernandez R, et al
    Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.
    Int J Gynaecol Obstet. 2020 Jun 11. doi: 10.1002/ijgo.13272.
    PubMed     Abstract available
    
    
    
61. KHADRAOUI W, Tierney C, Chung S, Mutlu L, et al
    Risk-stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low-risk endometrial cancer.
    Int J Gynaecol Obstet. 2020 Jun 7. doi: 10.1002/ijgo.13254.
    PubMed     Abstract available
    
    
    May 2020
62. YOSHIHARA M, Kajiyama H, Tamauchi S, Iyoshi S, et al
    Impact of uterus-preserving surgery on Stage I primary mucinous epithelial ovarian carcinoma: A multi-institutional study with propensity score-weighted analysis.
    Int J Gynaecol Obstet. 2020 May 29. doi: 10.1002/ijgo.13244.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.